Pain News and Research

Latest Pain News and Research

Autism Speaks grants $1M to Children's Hospital Los Angeles to improve GI symptoms associated with ASD

Pat Levitt, PhD, Simms/Mann Chair in Developmental Neurogenetics at Children's Hospital Los Angeles, has received a grant of nearly $1 million from Autism Speaks, the world's leading autism science and advocacy organization.

24 Oct 2014

Medicinal plant market goes untested for health hazards, shows study

Medicinal plant market goes untested for health hazards, according to a recent study published in journal Fungal Biology

24 Oct 2014

State highlights: Health care takes center stage in debates in Maine, Arizona, Missouri

The three candidates for governor clashed Tuesday in their final debate, highlighting their differences on a wide range of issues, including health care and welfare. Partisan sparks flew early and often between Republican Gov. Paul LePage and Democratic U.S. Rep. Mike Michaud, who are running in a dead heat in the race, far ahead of independent Eliot Cutler, two weeks before Maine residents go to the polls (10/21).

24 Oct 2014

electroCore’s gammaCore device effective for treating migraines, shows trial results

Preliminary results of an open-label trial carried in the journal of Headache and Pain reported that a single treatment with electroCore’s hand held non-invasive vagus nerve stimulation (nVNS) device gammaCore, completely resolved 44.8% of migraines within 30 minutes, with an additional 11.4% experiencing moderate benefits (incomplete resolution of their headaches) by 2 hours.

24 Oct 2014

Passengers from West Africa to start 3-week Ebola screening

The Centers for Disease Control and Prevention has announced that any person flying into the USA from Liberia, Sierra Leone or Guinea will soon have to undergo daily Ebola monitoring for several weeks after their arrival.

23 Oct 2014

HRQoL goals may improve outcome in PAH

Health-related quality of life before and during treatment for pulmonary arterial hypertension is significantly associated with survival, Brazilian researchers report.

22 Oct 2014

Analgesics, anti-inflammatory drugs have beneficial effect on treatment of depression

Ordinary over the counter painkillers and anti-inflammatory drugs purchased from pharmacies may also be effective in the treatment of people suffering of depression.

22 Oct 2014

Novel way for treating non-cardiac chest pain due to esophageal hypersensitivity

Chest pain doesn't necessarily come from the heart. An estimated 200,000 Americans each year experience non-cardiac chest pain, which in addition to pain can involve painful swallowing, discomfort and anxiety. Non-cardiac chest pain can be frightening for patients and result in visits to the emergency room because the painful symptoms, while often originating in the esophagus, can mimic a heart attack.

22 Oct 2014

Gastroenteropancreatic neuroendocrine tumors: an interview with Dr. Alexandria Phan

GEP-NETs stands for gastroenteropancreatic (GEP) neuroendocrine tumors (NETs). This is a type of rare cancer that is increasing in incidence and prevalence – more on this later.

22 Oct 2014

Omeros provides update on OMS824 for treatment of schizophrenia, Huntington's disease

Omeros Corporation today provided an update on OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor in development for the treatment of schizophrenia and Huntington's disease.

21 Oct 2014

Buprenorphine maintenance therapy better than detoxification for treating prescription opioid dependence

For treating patients with prescription opioid dependence in primary care, buprenorphine maintenance therapy is superior to detoxification, according to a new study by Yale School of Medicine researchers published in the Oct. 20 issue of JAMA Internal Medicine.

21 Oct 2014

Researchers unravel separate biological responses of the eye to blue light

Blue light can both set the mood and set in motion important biological responses. Researchers at the University of Pennsylvania's School of Medicine and School of Arts and Sciences have teased apart the separate biological responses of the human eye to blue light, revealing an unexpected contest for control.

21 Oct 2014

UB study: Males with IBS experience more interpersonal difficulties than females

One of the few studies to examine gender differences among patients with irritable bowel syndrome (IBS) has found that males with the condition experience more interpersonal difficulties than do females with the condition.

21 Oct 2014

IOF data shows 93% of US adults are unaware of men’s susceptibility to osteoporosis

New survey findings released by the International Osteoporosis Foundation (IOF) for World Osteoporosis Day show that on average, 93 percent of nearly 1,200 adults surveyed are unaware how common osteoporotic fractures are in men.

20 Oct 2014

RegeneRx to begin RGN-259 Phase 3 trials for treatment of neurotrophic keratopathy

RegeneRx Biopharmaceuticals, Inc. ("the Company" or "RegeneRx") today announced that it met with the FDA in September and as a result of the meeting may begin Phase 3 to evaluate RGN-259 preservative-free eye drops for the treatment of patients with neurotrophic keratopathy (NK), an orphan disease of the cornea.

20 Oct 2014

Qualified massage therapist can play key role in improving cardiovascular health

Many already view massage as an important approach to relieving muscle pain or as a means to relax. However, working with a qualified massage therapist can also play a significant role in improving cardiovascular health as evidenced by a growing body of research, according to the American Massage Therapy Association.

20 Oct 2014

Boston Scientific starts PLATINUM Diversity trial to evaluate Promus PREMIER Stent System

As part of its commitment to innovation and improving patient outcomes, Boston Scientific Corporation has initiated the PLATINUM Diversity trial to evaluate the clinical performance of the Promus PREMIER Everolimus-Eluting Platinum Chromium Coronary Stent System in underserved patient populations, including women and people of color.

20 Oct 2014

Janssen announces submission of IMBRUVICA sNDA to FDA for WM treatment

Janssen Research & Development, LLC today announced the submission of a supplemental New Drug Application (sNDA) for IMBRUVICA (ibrutinib) to the U.S. Food and Drug Administration by its strategic partner Pharmacyclics, Inc.

20 Oct 2014

Excess consumption of common pain relievers poses significant health risks to Australians

On the final day of Be Medicinewise Week 2014, NPS MedicineWise is reminding people that excess consumption of common pain relievers is a serious medicine safety issue.

20 Oct 2014

Anaesthesia editorial challenges placenta's role in pre-eclampsia

Pre-eclampsia, the potentially deadly condition that affects pregnant women, may be caused by problems meeting the oxygen demands of the growing fetus, according to an editorial in the November issue of Anaesthesia, the journal of the Association of Anaesthetists of Great Britain and Ireland.

20 Oct 2014

Pain News and Research

Latest Pain News and Research

Autism Speaks grants $1M to Children's Hospital Los Angeles to improve GI symptoms associated with ASD

Medicinal plant market goes untested for health hazards, shows study

State highlights: Health care takes center stage in debates in Maine, Arizona, Missouri

electroCore’s gammaCore device effective for treating migraines, shows trial results

Passengers from West Africa to start 3-week Ebola screening

HRQoL goals may improve outcome in PAH

Analgesics, anti-inflammatory drugs have beneficial effect on treatment of depression

Novel way for treating non-cardiac chest pain due to esophageal hypersensitivity

Gastroenteropancreatic neuroendocrine tumors: an interview with Dr. Alexandria Phan

Omeros provides update on OMS824 for treatment of schizophrenia, Huntington's disease

Buprenorphine maintenance therapy better than detoxification for treating prescription opioid dependence

Researchers unravel separate biological responses of the eye to blue light

UB study: Males with IBS experience more interpersonal difficulties than females

IOF data shows 93% of US adults are unaware of men’s susceptibility to osteoporosis

RegeneRx to begin RGN-259 Phase 3 trials for treatment of neurotrophic keratopathy

Qualified massage therapist can play key role in improving cardiovascular health

Boston Scientific starts PLATINUM Diversity trial to evaluate Promus PREMIER Stent System

Janssen announces submission of IMBRUVICA sNDA to FDA for WM treatment

Excess consumption of common pain relievers poses significant health risks to Australians

Anaesthesia editorial challenges placenta's role in pre-eclampsia

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Pain News and Research

Latest Pain News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in